Portal de investigação
A importância do diagnóstico na Fibrose Pulmonar Idiopática
Dados básicos
- Código:
- Estudo Clínico Académico (FPI)
- Protocolo:
- Estudo Clínico Académico (FPI)
- EUDRACT:
- NCT:
- Centro:
- Dotação:
- Ano de início:
- 2020
- Ano de conclusão:
Objectivos do projeto
Estudos Observacionais (STROBE statement); Natureza do Promotor: Academia – Tipo não comercial – Iniciativa do Investigador; Tipo de Centro: Unicêntrico – Cuidados Secundários
Documentos
- Não há documentos
Participantes
Unidades de investigação
Stakeholders - Promotores
Outputs do ensaio clínico
EGFR Assessment in Lung Cancer CT Images: Analysis of Local and Holistic Regions of Interest Using Deep Unsupervised Transfer Learning
Silva, Francisco; (...); Oliveira, Helder P.
Article. 10.1109/ACCESS.2021.3070701. 2021
Atezolizumab in previously treated non-smallcell lung cancer patients
Serino, M; (...); Hespanhol, V
Meeting Abstract. 10.1183/13993003.congress-2021.PA2304. 2021
Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer
Fernandes, MGO; (...); Costa, JL
Article. 10.3390/cancers13112707. 2021
Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer.
Fernandes, MGO; (...); Costa, JL
Article. 2021
Comprehensive Perspective for Lung Cancer Characterisation Based on AI Solutions Using CT Images
Pereira, T; (...); Oliveira, HP
Article. 10.3390/jcm10010118. 2021
COPD: How can evidence from randomised controlled trials apply to patients treated in everyday clinical practice?
Duarte de Ara?jo, A; (...); Correia de Sousa, J
Article. 10.1016/j.pulmoe.2020.02.003. 2022
COVID-19 in Patients with Lung Cancer - Experience from a Thoracic Oncology Center
Coelho, D; (...); Fernandes, G
Meeting Abstract. 2021
Immune-Related Adverse Effects of Immunotherapy in Patients With Advanced Non-Small Cell Lung Carcinoma
Freitas, C; (...); Fernandes, G
Meeting Abstract. 2021
Immunotherapy in metastatic non-small cell lung cancer: EPSILoN as a prognostic score
Valente, MCA; (...); Hespanhol, V
Meeting Abstract. 10.1183/13993003.congress-2022.3572. 2022
Implementation of a Pilot Study to Analyze Circulating Tumor DNA in Early-Stage Lung Cancer
Espiga De Macedo, J; (...); Hespanhol, V
Article. 10.20344/amp.19487. 2023
Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic
Fernandes, MGO; (...); Hespanhol, V
Article. 10.3390/cells10081912. 2021
Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic.
Fernandes, MGO; (...); Hespanhol, V
Article. 2021
Liquid biopsy: the value of different bodily fluids
Santos, V; (...); Campelo, R
Review. 10.2217/bmm-2021-0370. 2022
Lung CT image synthesis using GANs
Mendes, J; (...); Oliveira, HP
Article. 10.1016/j.eswa.2022.119350. 2023
Lung nodules: a diagnosis' challenge in Pulmonology
Martins, Mariana Ramos; (...); Hespanhol, Venceslau
Meeting Abstract. 10.1183/13993003.congress-2021.PA2180. 2021
Machine Learning and Feature Selection Methods for EGFR Mutation Status Prediction in Lung Cancer
Morgado, J; (...); Oliveira, HP
Article. 10.3390/app11073273. 2021
Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center
Coelho, DB; (...); Fernandes, MGO
Article. 10.3389/fmolb.2021.639676. 2021
Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center.
Coelho, DB; (...); Fernandes, MGO
Article. 2021
Modified Glasgow Prognostic Score predicts survival among advanced non-small cell lung carcinoma patients treated with anti-PD1 agents.
Freitas, C; (...); Queiroga, H
Article. 2021
Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position Paper
Barata, F; (...); Hespanhol, V
Article. 10.1007/s40264-021-01083-x. 2021
Multiple instance learning for lung pathophysiological findings detection using CT scans
Frade, J; (...); Oliveira, HP
Article. 10.1007/s11517-022-02526-y. 2022
Pneumonia mortality, comorbidities matter? Authors' answer
Hespanhol, V, Barbara, Cristina
Letter. 10.1016/j.pulmoe.2020.09.005. 2021
PREDICTIVE BIOMARKERS OF SEVERE IMMUNE-RELATED ADVERSE EVENTS IN NON-SMALL CELL LUNG CANCER
Magalhaes Ferreira, P.; (...); Hespanhol, V.
Meeting Abstract. 10.1016/j.chest.2021.12.341. 2022
Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors.
Serino, M; (...); Hespanhol, V
Article. 2024
Pre-Training Autoencoder for Lung Nodule Malignancy Assessment Using CT Images
Silva, F; (...); Oliveira, HP
Article. 10.3390/app10217837. 2020
Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients
Coelho, DJAB; (...); Fernandes, G
Meeting Abstract. 10.1183/13993003.congress-2020.1694. 2020
Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer
Fernandes, MGO; (...); Hespanhol, V
Article. 10.3389/fonc.2021.602924. 2021
Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer.
Fernandes, MGO; (...); Hespanhol, V
Article. 2021
Sharing Biomedical Data: Strengthening AI Development in Healthcare
Pereira, T; (...); Oliveira, HP
Article. 10.3390/healthcare9070827. 2021
SOMATOSTATIN ANALOGS IN THE TREATMENT OF LUNG CARCINOID TUMORS: AN EXPERIENCE OF A LARGE CENTER
Valente, A.; (...); Queiroga, H.
Meeting Abstract. 10.1016/j.chest.2021.12.347. 2022
Spread through air spaces prognostic value in adenocarcinoma
Silva Sousa, Mara Daniela; (...); Freitas, Claudia
Meeting Abstract. 10.1183/13993003.congress-2023.PA2214. 2023
T790M-EGFR mutation frequency in advanced NSCLC patients on progression from a previous TKI therapy: results from a Portuguese study
Teixeira, Encarnacao; (...); Barata, Fernando
Letter. 10.1016/j.pulmoe.2021.01.007. 2021
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
Freitas, Claudia; (...); Hespanhol, Venceslau
Review. 10.3389/fonc.2021.634316. 2021
The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management
Fernandes, MGO; (...); Hespanhol, V
Review. 10.1186/s12935-021-02382-0. 2021
The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management.
Fernandes, MGO; (...); Hespanhol, V
Review. 2021
Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges
Silva, F; (...); Oliveira, HP
Article. 10.3390/jpm12030480. 2022
